The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
Open accessAbstract
Blood biomarkers have great potential to advance clinical care and accelerate trials in Alzheimer's disease (AD). Plasma phospho-tau181 (p-tau181) is a promising blood biomarker however, it is unknown if levels increase in presymptomatic AD. Therefore, we investigated the timing of p-tau181 changes using 153 blood samples from 70 individuals in a longitudinal study of familial AD (FAD). Plasma p-tau181 was measured, using an in-house single molecule array assay. We compared p-tau181 between symptomatic carriers, presymptomatic carriers, and non-carriers, adjusting for age and sex. We examined the relationship between p-tau181 and neurofilament light and estimated years to/from symptom onset (EYO), as well as years to/from actual onset in a symptomatic subgroup. In addition, we studied associations between p-tau181 and clinical severity, as well testing for differences between genetic subgroups. Twenty-four were presymptomatic carriers (mean baseline EYO -9.6 years) while 27 were non-carriers. Compared with non-carriers, plasma p-tau181 concentration was higher in both symptomatic (p < 0.001) and presymptomatic mutation carriers (p < 0.001). Plasma p-tau181 showed considerable intra-individual variability but individual values discriminated symptomatic (AUC 0.93 [95% CI 0.85-0.98]) and presymptomatic (EYO ≥ -7 years) (AUC 0.86 [95% CI 0.72-0.94]) carriers from non-carriers of the same age and sex. From a fitted model there was evidence (p = 0.050) that p-tau181 concentrations were higher in mutation carriers than non-carriers from 16 years prior to estimated symptom onset. Our finding that plasma p-tau181 concentration is increased in symptomatic and presymptomatic FAD suggests potential utility as an easily accessible biomarker of AD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This relationship is observed across the AD continuum, including the asymptomatic phase in sporadic and genetic forms of AD.11,12,13,14”
From Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology (2024) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
White, H. (1980) · Econometrica · doi:10.2307/1912934 · Cited by 25,861
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Self-citationThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
(1967) · Project Euclid (Cornell University) · Cited by 4,720
Cited by
Sorted by citations
Biomarkers for neurodegenerative diseases
Hansson, O. (2021) · Nature Medicine · doi:10.1038/s41591-021-01382-x · Cited by 1,159
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00361-6 · Cited by 1,045
Self-citationDiagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
Ashton, N. J., Brum, W. S., Di Molfetta, G., Benedet, A. L., Arslan, B., Jonaitis, E., Langhough, R. E., Cody, K., Wilson, R., Carlsson, C. M., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2023.5319 · Cited by 884
Self-citationTau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
Ossenkoppele, R., van der Kant, R., & Hansson, O. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00168-5 · Cited by 557
Karikari, T. K., Benedet, A. L., Ashton, N. J., Lantero‐Rodriguez, J., Snellman, A., Suárez‐Calvet, M., Saha‐Chaudhuri, P., Lussier, F. Z., Kvartsberg, H., Moscoso, A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00923-z · Cited by 361
Self-citationBlood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
Karikari, T. K., Ashton, N. J., Brinkmalm, G., Brum, W. S., Benedet, A. L., Montoliu‐Gaya, L., Lantero‐Rodriguez, J., Pascoal, T. A., Suárez‐Calvet, M., Rosa‐Neto, P., et al. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00665-2 · Cited by 333
Self-citationChatterjee, P., Pedrini, S., Doecke, J. D., Thota, R. N., Villemagne, V. L., Doré, V., Singh, A. K., Wang, P., Rainey‐Smith, S. R., Fowler, C. J., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12724 · Cited by 331
Moscoso, A., Grothe, M. J., Ashton, N. J., Karikari, T. K., Lantero‐Rodriguez, J., Snellman, A., Suárez‐Calvet, M., Blennow, K., Zetterberg, H., Schöll, M., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.4986 · Cited by 314
Self-citationNeurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
Yuan, A., & Nixon, R. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.689938 · Cited by 304
Therriault, J., Vermeiren, M. R., Servaes, S., Tissot, C., Ashton, N. J., Benedet, A. L., Karikari, T. K., Lantero‐Rodriguez, J., Brum, W. S., Lussier, F. Z., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.4485 · Cited by 278
Self-citationCSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
Horie, K., Salvadó, G., Barthélemy, N. R., Janelidze, S., Li, Y., He, Y., Saef, B., Chen, C. D., Jiang, H., Strandberg, O., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02443-z · Cited by 249
Mielke, M. M., Frank, R. D., Dage, J. L., Jeromin, A., Ashton, N. J., Blennow, K., Karikari, T. K., Vanmechelen, E., Zetterberg, H., Algeciras-Schimnich, A., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.2293 · Cited by 244
Self-citationTime course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum
Moscoso, A., Grothe, M. J., Ashton, N. J., Karikari, T. K., Rodriguez, J. L., Snellman, A., Suárez-Calvet, M., Zetterberg, H., Blennow, K., Schöll, M., et al. (2021) · Brain · doi:10.1093/brain/awaa399 · Cited by 229
Self-citationMoving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Zetterberg, H., & Blennow, K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00430-x · Cited by 219
Self-citationPlasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
González‐Ortiz, F., Kac, P. R., Brum, W. S., Zetterberg, H., Blennow, K., & Karikari, T. K. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00605-8 · Cited by 235
Self-citationPlasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease
Stevenson‐Hoare, J. O., Heslegrave, A., Leonenko, G., Fathalla, D., Bellou, E., Luckcuck, L., Marshall, I. J., Sims, R., Morgan, B. P., Hardy, J., et al. (2022) · Brain · doi:10.1093/brain/awac128 · Cited by 191
Self-citationBlood–brain barrier link to human cognitive impairment and Alzheimer’s disease
Barisano, G., Montagne, A., Kisler, K., Schneider, J. A., Wardlaw, J. M., & Zlokovic, B. V. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-021-00014-4 · Cited by 157
Karikari, T. K., Emeršič, A., Vrillon, A., Lantero‐Rodriguez, J., Ashton, N. J., Kramberger, M. G., Dumurgier, J., Hourregue, C., Čučnik, S., Brinkmalm, G., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12236 · Cited by 143
Self-citationAshton, N. J., Leuzy, A., Karikari, T. K., Mattsson-Carlgren, N., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Nordberg, A., Ossenkoppele, R., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05253-y · Cited by 142
Self-citationChallenges in the practical implementation of blood biomarkers for Alzheimer’s disease
Schöll, M., Verberk, I. M. W., del Campo, M., Delaby, C., Therriault, J., Chong, J. R., Palmqvist, S., & Alcolea, D. A. (2024) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2024.07.013 · Cited by 150
Blood Biomarkers in Neurodegenerative Diseases
Alcolea, D. A., Beeri, M. S., Rojas, J. C., Gardner, R. C., & Lleó, A. (2023) · Neurology · doi:10.1212/wnl.0000000000207193 · Cited by 123
Staging of Alzheimer’s disease: past, present, and future perspectives
Therriault, J., Zimmer, E. R., Benedet, A. L., Pascoal, T. A., Gauthier, S. G., & Rosa‐Neto, P. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.05.008 · Cited by 123
Chong, J. R., Ashton, N. J., Karikari, T. K., Tanaka, T., Schöll, M., Zetterberg, H., Blennow, K., Chen, C., & Lai, M. K. P. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-327370 · Cited by 111
Self-citationAlawode, D. O. T., Heslegrave, A., Ashton, N. J., Karikari, T. K., Simrén, J., Montoliu‐Gaya, L., Pannee, J., O’Connor, A., Weston, P. S. J., Lantero‐Rodriguez, J., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13332 · Cited by 107
Self-citationGleason, C. E., Zuelsdorff, M., Gooding, D. C., Kind, A. J. H., Johnson, A. L., James, T. T., Lambrou, N. H., Wyman, M. F., Ketchum, F. B., Gee, A., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12511 · Cited by 104
Self-citationChong, J. R., Ashton, N. J., Karikari, T. K., Tanaka, T., Saridin, F. N., Reilhac, A., Robins, E. G., Nai, Y., Vrooman, H. A., Hilal, S., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12332 · Cited by 97
Self-citationLongitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid
Bilgel, M., An, Y., Walker, K. A., Moghekar, A., Ashton, N. J., Kac, P. R., Karikari, T. K., Blennow, K., Zetterberg, H., Jedynak, B., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13157 · Cited by 93
Self-citationJanigro, D., Bailey, D. M., Lehmann, S., Badaut, J., O’flynn, R., Hirtz, C., & Marchi, N. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.577312 · Cited by 98
Plasma biomarker profiles in autosomal dominant Alzheimer’s disease
Johansson, C., Þórðardóttir, S., Laffita‐Mesa, J. M., Rodriguez‐Vieitez, E., Zetterberg, H., Blennow, K., & Graff, C. (2022) · Brain · doi:10.1093/brain/awac399 · Cited by 80
Self-citationLleó, A., Zetterberg, H., Pegueroles, J., Karikari, T. K., Carmona-Iragui, M., Ashton, N. J., Montal, V., Barroeta, I., Lantero-Rodríguez, J., Videla, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24319-x · Cited by 72
Self-citationWang, Y., Chen, J., Du, Z., Weng, H., Zhang, Y., Li, R., Jia, Z., Sun, M., Jiang, J., Wang, F.-Z., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.695696 · Cited by 64
Ding, X., Zhang, S., Jiang, L., Wang, L., Li, T., & Lei, P. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00234-5 · Cited by 61
Fluid biomarkers in Alzheimer's disease
Simrén, J., Elmgren, A., Blennow, K., & Zetterberg, H. (2023) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2022.09.006 · Cited by 58
Self-citationGobom, J., Benedet, A. L., Mattsson, N., Montoliu‐Gaya, L., Schultz, N., Ashton, N. J., Janelidze, S., Servaes, S., Sauer, M., Pascoal, T. A., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00586-0 · Cited by 57
Self-citationInitiative*, T. A. D. N., Zettergren, A., Lord, J., Ashton, N. J., Benedet, A. L., Karikari, T. K., Lantero‐Rodriguez, J., Snellman, A., Suárez‐Calvet, M., Proitsi, P., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00754-8 · Cited by 55
Self-citationAssociation of plasma P-tau181 with memory decline in non-demented adults
Therriault, J., Benedet, A. L., Pascoal, T. A., Lussier, F. Z., Tissot, C., Karikari, T. K., Ashton, N. J., Chamoun, M., Bezgin, G., Mathotaarachchi, S., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab136 · Cited by 56
Self-citationPerformance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease
Wilson, E. N., Young, C. B., Benitez, J. A. R., Swarovski, M. S., Feinstein, I., Vandijck, M. L. J., Guen, Y. L., Kasireddy, N. M., Shahid, M., Corso, N. K., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01116-2 · Cited by 51
Moscoso, A., Karikari, T. K., Grothe, M. J., Ashton, N. J., Lantero‐Rodriguez, J., Snellman, A., Zetterberg, H., Blennow, K., & Schöll, M. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12570 · Cited by 50
Self-citationNeurodegenerative disease of the brain: a survey of interdisciplinary approaches
Davenport, F., Gallacher, J., Kourtzi, Z., Koychev, I. G., Matthews, P. M., Oxtoby, N. P., Parkes, L. M., Priesemann, V., Rowe, J. B., Smye, S. W., et al. (2023) · Journal of The Royal Society Interface · doi:10.1098/rsif.2022.0406 · Cited by 50
Self-citationAshton, N. J., Brum, W. S., Molfetta, G. D., Benedet, A. L., Arslan, B., Jonaitis, E. M., Langhough, R. E., Cody, K. A., Wilson, R. H., Carlsson, C. M., et al. (2023) · medRxiv · doi:10.1101/2023.07.11.23292493 · Cited by 50
Self-citationBiomarkers of Alzheimer’s disease: Past, present and future clinical use
Georgakas, J. E., Howe, M. D., Thompson, L. I., Riera, N. M., & Riddle, M. C. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100063 · Cited by 52
Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
Montoliu‐Gaya, L., Strydom, A., Blennow, K., Zetterberg, H., & Ashton, N. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163639 · Cited by 46
Self-citationFrank, B. E., Ally, M., Brekke, B., Zetterberg, H., Blennow, K., Sugarman, M. A., Ashton, N. J., Karikari, T. K., Tripodis, Y., Martin, B. M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12508 · Cited by 40
Self-citationO’Connor, A., Abel, E., Benedet, A. L., Poole, T., Ashton, N. J., Weston, P. S. J., Heslegrave, A., Ryan, N. S., Barker, S., Polke, J. M., et al. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-329663 · Cited by 45
Self-citationMcGrath, E. R., Beiser, A., O’Donnell, A., Yang, Q., Ghosh, S., Gonzales, M. M., Himali, J. J., Satizábal, C. L., Johnson, K. A., Tracy, R. P., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215639 · Cited by 37
Plasma phosphorylated tau181 predicts cognitive and functional decline
Tropea, T. F., Waligórska, T., Xie, S. X., Nasrallah, I. M., Cousins, K. A. Q., Trojanowski, J. Q., Grossman, M., Irwin, D. J., Weintraub, D. A., Lee, E. B., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51695 · Cited by 39
Biomarkers in neurodegenerative diseases: a broad overview
Sathish, S., & Ayyavoo, V. (2024) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2024.00075 · Cited by 39
Chen, J., Zhao, X. Y., Zhang, W., Zhang, T., Wu, S., Shao, J., & Shi, F. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01246-1 · Cited by 33
Álvarez-Sánchez, L., Peña-Bautista, C., Ferré-González, L., Balaguer, A., Baquero, M., Casanova-Estruch, B., & Cháfer-Pericás, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021226 · Cited by 32
A critical appraisal of blood-based biomarkers for Alzheimer’s disease
Lista, S., Mapstone, M. E., Caraci, F., Emanuele, E., López‐Ortiz, S., Martín-Hernández, J., Triaca, V., Imbimbo, C., Gabelle, A., Mielke, M. M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102290 · Cited by 30
Pilotto, A., Parigi, M., Bonzi, G., Battaglio, B., Ferrari, E., Mensi, L., Benussi, A., Caratozzolo, S., Cosseddu, M., Turrone, R., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215646 · Cited by 28
Self-citationProvost, K., Iaccarino, L., Soleimani‐Meigooni, D. N., Baker, S. L., Edwards, L., Eichenlaub, U., Hansson, O., Jagust, W. J., Janabi, M., Joie, R. L., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05152-8 · Cited by 27
Tau proteins in blood as biomarkers of Alzheimer’s disease and other proteinopathies
Verde, F. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02471-y · Cited by 26
Dityrosine cross-linking and its potential roles in Alzheimer’s disease
Maina, M. B., Al‐Hilaly, Y. K., & Serpell, L. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1132670 · Cited by 27
Thomas, K. R., Bangen, K. J., Edmonds, E. C., Weigand, A. J., Walker, K. S., Bondi, M. W., Galasko, D. R., & Initiative, A. D. N. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12238 · Cited by 25
Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
Yu, X., Shao, K., Wan, K., Li, T., Li, Y., Zhu, X., & Han, Y. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002566 · Cited by 23
Álvarez‐Sánchez, L., Peña‐Bautista, C., Baquero, M., & Cháfer‐Pericás, C. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215093 · Cited by 25
Eastwood, S., Meyer, M. R., Kirmess, K. M., Wente‐Roth, T. L., Irvin, F., Holubasch, M. S., Verghese, P. B., West, T., Braunstein, J. B., Yarasheski, K. E., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14161739 · Cited by 23
Gleerup, H. S., Sanna, F., Høgh, P., Simrén, J., Blennow, K., Zetterberg, H., Hasselbalch, S. G., Ashton, N. J., & Simonsen, A. H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.659898 · Cited by 21
Self-citationMolina‐Henry, D. P., Langford, O., Donohue, M., Raman, R., Aisen, P. S. S., Johnson, K. A., Rissman, R. A., & Sperling, R. A. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.124 · Cited by 20
Nabizadeh, F., Pourhamzeh, M., Khani, S., Rezaei, A., Ranjbaran, F., Deravi, N., & ADNI (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00908-7 · Cited by 19
An Introduction to Ultrasensitive Assays for Plasma Tau Detection
Ding, X., Tuo, Q., & Lei, P. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201499 · Cited by 20
Licinio, J., & Wong, M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01968-6 · Cited by 18
Plasma p-tau181 and amyloid markers in Alzheimer’s disease: A comparison between Lumipulse and SIMOA
Quaresima, V., Pilotto, A., Trasciatti, C., Tolassi, C., Parigi, M., Bertoli, D., Mordenti, C., Galli, A., Rizzardi, A., Caratozzolo, S., et al. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.08.007 · Cited by 22
Self-citationYu, F., Han, S., Salisbury, D. L., Pruzin, J. J., Geda, Y. E., Caselli, R. J., & Li, D. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-01200-2 · Cited by 18
Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
Toniolo, S., Zhao, S., Scholcz, A., Amein, B., Ganse‐Dumrath, A., Heslegrave, A., Thompson, S., Manohar, S., Zetterberg, H., & Husain, M. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12590 · Cited by 19
Self-citationTaneva, S. G., Todinova, S. J., & Andreeva, T. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814296 · Cited by 17
Carmona‐Iragui, M., O’Connor, A., Llibre‐Guerra, J. J., Lao, P. J., Ashton, N. J., Fortea, J., & Sánchez‐Valle, R. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105327 · Cited by 13
Self-citationValverde, A., Pidal, J. M. G., Montero‐Calle, A., Arévalo, B., Serafín, V., Calero, M., Moreno‐Guzmán, M., López, M. Á., Escarpa, A., Yáñez‐Sedeño, P., et al. (2022) · ChemElectroChem · doi:10.1002/celc.202200055 · Cited by 12
Tau biomarkers for neurodegenerative diseases: Current state and perspectives
Vacchi, E., Ruíz‐Barrio, I., & Melli, G. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.107772 · Cited by 11
Circulating Biomarkers for the Early Diagnosis of Alzheimer’s Disease
Nunkoo, V. S., Jurcău, A., Les, M., Cristian, A., Militaru, M., Marge, C., Iovanovici, D. C., & Jurcău, M. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157268 · Cited by 13
Jiang, L., Ding, X., Wang, W., Yang, X., Li, T., & Lei, P. (2022) · Biomolecules · doi:10.3390/biom12091194 · Cited by 12
Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer’s disease
Lu, K., Nicholas, J. M., Weston, P. S. J., Stout, J. C., O’Regan, A., James, S., Buchanan, S. M., Lane, C., Parker, T. D., Keuss, S. E., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab003 · Cited by 11
Self-citationBlutbasierte Biomarker zur Optimierung der Früh- und Differentialdiagnostik der Alzheimer-Demenz
Hansen, N., Rauter, C. M., & Wiltfang, J. (2022) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-1839-6237 · Cited by 10
Plasma Phospho-Tau-181 as a Diagnostic Aid in Alzheimer’s Disease
Tsantzali, I., Foska, A., Sideri, E., Routsi, E., Tsomaka, E., Kitsos, D. K., Zompola, C., Bonakis, A., Giannopoulos, S., Voumvourakis, K. I., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10081879 · Cited by 9
Blood-Based Biomarkers for Early Alzheimer’s Disease Diagnosis in Real-World Settings
Perneczky, R., Hansen, N., Hofmann, A., Laske, C., Priller, J., Grimmer, T., Frölich, L., Düzel, E., Jessen, F., & Wiltfang, J. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3774-6_1 · Cited by 12
Zhang, Y., Yang, Y., Hu, Z., Zhu, M., Qin, S., Yu, P., Li, B., Xu, J., Ondrejčák, T., Klyubin, I. V., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220351 · Cited by 8
The emerging role of blood biomarkers in diagnosis and treatment of Alzheimer’s disease
McGettigan, S., Nolan, Y. M., Ghosh, S. K., & O’Mahony, D. (2023) · European Geriatric Medicine · doi:10.1007/s41999-023-00847-1 · Cited by 7
Davidson, C. E. D., & Prakash, R. (2025) · Biosensors · doi:10.3390/bios15040228 · Cited by 7
Giudici, K. V., Barreto, P. D. S., Guyonnet, S., Cantet, C., Zetterberg, H., Boschat, C., Hudry, J., Andrieu, S., Schmitt, J. A. J., Vellas, B. J., et al. (2023) · Journal of Aging Research and Lifestyle · doi:10.14283/jarlife.2023.7 · Cited by 7
Self-citationSingh, K., Cheung, B. M. Y., & Xu, A. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2021-0219 · Cited by 7
Molecular Psychiatry special issue: advances in Alzheimer’s disease
Licinio, J., & Wong, M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01434-1 · Cited by 5
Shim, Y. (2023) · Current Alzheimer Research · doi:10.2174/0115672050284054240119101834 · Cited by 5
Wu, L., Zhang, R., Wang, Y., Dai, S., & Yang, N. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1571783 · Cited by 4
Dyer, A. H., Dolphin, H., O’Connor, A., Morrison, L., Sedgwick, G., McFeely, A., Killeen, E., Gallagher, C., Davey, N., Connolly, E., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-077772 · Cited by 5
Self-citationTropea, T. F., Waligórska, T., Xie, S. X., Nasralah, I. M., Cousins, K. A. Q., Trojanowski, J. Q., Grossman, M., Irwin, D. J., Weintraub, D. A., Lee, E. B., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4007185 · Cited by 4
Johansson, C., Þórðardóttir, S., Laffita‐Mesa, J. M., Pannee, J., Rodriguez‐Vieitez, E., Zetterberg, H., Blennow, K., & Graff, C. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01574-w · Cited by 4
Self-citationIdris, M., Saini, F., Ivain, P., Baksh, R. A., Bianchi, L. A., Pape, S. E., Zetterberg, H., Wijeratne, P. A., & Strydom, A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70446 · Cited by 3
Self-citationMao, C., Mo, Y., Jiang, J., Fang, S., Hu, Z., Ke, Z., Zhao, H., & Xu, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-94472-6 · Cited by 3
Early Diagnosis of Alzheimer's Disease with Blood Test; Tempting but Challenging.
Farvadi, F., Hashemi, F., Amini, A., Vakilinezhad, M. A., & Raee, M. J. (2023) · PubMed Central · doi:10.22088/ijmcm.bums.12.2.172 · Cited by 3
Quaresima, V., Pilotto, A., Trasciatti, C., Tolassi, C., Parigi, M., Bertoli, D., Mordenti, C., Galli, A., Rizzardi, A., Caratozzolo, S., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4774535 · Cited by 3
Self-citationBlood biomarkers of Alzheimer’s disease: important considerations for use in clinical practice
Fullam, S., O’Dowd, S., & O’Connor, A. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-02017 · Cited by 2
Self-citationProteomics As A Valid Tool In Biomarker Discovery For Alzheimer's DiseasePreprint
Magnelli, V. (2024) · Preprints.org · doi:10.20944/preprints202401.1595.v1 · Cited by 1
Implications of AD plasma and PET biomarker discordance
Teunissen, C. E., & Vermunt, L. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01091-w · Cited by 1
Rogacz, Z., Pacuła, W., Strzałka‐Mrozik, B., & Turek, A. (2026) · Applied Sciences · doi:10.3390/app16052554 · Cited by 2
Nabizadeh, F., Jameie, S. B., Khani, S., Rezaei, A., Ranjbaran, F., Deravi, N., & Pourhamzeh, M. (2021) · Research Square · doi:10.21203/rs.3.rs-115316/v3
Recent advances in blood and gut microbiota biomarkers for Alzheimer’s disease
Wu, S., Li, H., Tong, L., & Zhou, L. I. U. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0100
Development of Fluid Biomarkers for Alzheimer’s Disease
Blennow, K. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.033
Self-citationZhang, Y., Yang, Y., Hu, Z., Zhu, M., Qin, S., Peng, Y., Li, B., Xu, J.-T., Rowan, M., & Hu, N.-W. (2022) · bioRxiv · doi:10.1101/2022.03.28.486022
Wolff, A. W., Demleitner, A. F., Feneberg, E., & Lingor, P. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01654-0
Metadata
- Authors
- O’Connor, A., Karikari, T. K., Poole, T., Ashton, N. J., Lantero Rodriguez, J., Khatun, A., Swift, I., Heslegrave, A. J., Abel, E., Chung, E., Weston, P. S. J., Pavisic, I. M., Ryan, N. S., Barker, S., Rossor, M. N., Polke, J. M., Frost, C., Mead, S., Blennow, K., Zetterberg, H., & Fox, N. C.
- Affiliations
- UK Dementia Research Institute (GB)
- University of Gothenburg (SE)
- London School of Hygiene & Tropical Medicine (GB)
- King's College London (GB)
- UCL Queen Square Institute of Neurology (GB)
- University College London Hospitals NHS Foundation Trust (GB)
- Sahlgrenska University Hospital (SE)
- Corresponding author
- Zetterberg, Henrik
- Fox, Nick C.
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 2020-07-14
- Volume
- 26
- Issue
- 10
- Pages
- 5967-5976
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC7612227
- OpenAlex
- W3043470682
- Cited by
- 122
- References
- 47
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 16 · 2023: 19 · 2022: 33 · 2021: 28 · 2020: 3
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Alzheimer's Society
- National Institute for Health and Care Research (NF-SI-0617-10175)
- Rosetrees Trust (M668-CD1)
- Medical Research Council (MR/L023784/2, MR/M003108/1, MR/L023784/1)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- familial Alzheimer's disease, preclinical Alzheimer's disease, blood biomarkers, neurofilament light chain, mutation carriers, clinical severity, early detection of Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Humans, Longitudinal Studies, Cohort Studies, Biomarkers, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
